Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
Condition(s):Solid CarcinomaLast Updated:February 17, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Solid CarcinomaLast Updated:February 17, 2020Unknown status
Condition(s):Advanced Renal Cell Carcinoma (aRCC)Last Updated:July 1, 2022Completed
Condition(s):MelanomaLast Updated:February 24, 2021Completed
Condition(s):Kidney Cancer; Clear Cell Renal Cell Carcinoma Metastatic; Synchronous NeoplasmLast Updated:June 22, 2023Recruiting
Condition(s):Kidney Cancer; Renal Cell Cancer MetastaticLast Updated:February 20, 2024Not yet recruiting
Condition(s):Malignancy; Immune System Diseases; Autoimmune DiseasesLast Updated:January 31, 2024Recruiting
Condition(s):Head and Neck Cancer; Advanced Cancer; Metastatic Cancer; HNSCC; Squamous Cell CarcinomaLast Updated:May 19, 2022Completed
Condition(s):Multiple Myeloma; Relapsed Refractory Multiple MyelomaLast Updated:July 28, 2023Active, not recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:September 22, 2022Recruiting
Condition(s):Non-small Cell Lung Cancer PatientsLast Updated:June 26, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.